Artelo Biosciences Announces Pricing Of $8.0 Million Public Offering And Uplisting To Nasdaq
June 22, 2019 at 23:30 PM EDT
In connection with the offering, the Company has effectuated a reverse split of its common stock at a ratio of 1-for-8.
